Medicare Low Income Subsidy Equality Act of 2026
Key claim: A newly introduced House bill would address equality in Medicare’s Low-Income Subsidy for prescription-drug costs, but it has only been referred to committee and does not change current law.
Abstract
(HR10874 · 119th Congress) Latest action (2026-10-22): Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Why this matters
The Low-Income Subsidy helps millions of low-income Medicare beneficiaries pay Part D prescription-drug premiums, deductibles, and copays, so even eligibility-tweak proposals matter to out-of-pocket drug costs. At the introduced stage, this bill does not change what any beneficiary pays, but it signals continued congressional attention to disparities in LIS access.